LA
NEUE

Lee Ainslie’s NeueHealth NEUE Stock Holding History

Lee Ainslie’s Portfolio NEUE Stock Details NEUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-21,456
Closed -$5.91M – 394
2021
Q4 		$5.91M Sell
21,456
-13,544
-39% -$6.25M 0.07% 79
2021
Q3 		$22.8M Hold
35,000
– – 0.23% 63
2021
Q2 		$48M Buy
+35,000
New +$48M 0.45% 42

Other funds holding NEUE

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
DMC
Deer Management Company Larchmont, New York $812M AUM 2.64% 1-Year Est. Return
SG
StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return
RM
Redpoint Management Woodside, California $204M AUM 31.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
G
Greycroft New York $44.1M AUM 24.2% 1-Year Est. Return
MCAV
Meritech Capital Associates VI Palo Alto, California $45.3M AUM 4.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PGH
Partners Group Holding Baar-Zug, Switzerland $1.47B AUM 8.59% 1-Year Est. Return
LWAM
Legacy Wealth Asset Management Woodbury, Minnesota $456M AUM 35.19% 1-Year Est. Return

Lee Ainslie's NEUE Position: Q1 2022 in Review

Lee Ainslie sold out of NeueHealth (NEUE) in Q1 2022, closing a stake of 21,456 shares — an estimated $5.91M sold.

Lee Ainslie first reported a position in NEUE in Q2 2021 and held it in 3 quarters. The position peaked at $48M in Q2 2021. 121 funds tracked by Wall St. Rank hold NEUE as of Q1 2022.

  • Lee Ainslie reported no remaining NeueHealth position as of Q1 2022 after selling out during the quarter.
  • Lee Ainslie sold 21,456 NeueHealth shares in Q1 2022, an estimated $5.91M.
  • Lee Ainslie first reported a position in NeueHealth in Q2 2021 and held it in 3 quarters.
  • Lee Ainslie's NeueHealth position peaked at $48M in Q2 2021.
  • 121 funds tracked by Wall St. Rank held NeueHealth as of Q1 2022.

Based on Maverick Capital's 13F filing for Q1 2022, filed 16 May 2022.